A Novel Classification of Esophageal Anastomotic Leaks and Its Impact on Healing Time After Esophagogastrostomy [0.03%]
食管吻合术后食管吻合口漏的新分类及其对愈合时间的影响
Zhao Ma,Jie Zheng,Hongbo Wang et al.
Zhao Ma et al.
Purpose: Anastomotic leakage (AL) is a severe complication after esophagogastrostomy, yet the classifications of AL and their associated healing times are poorly understood. ...
Understanding the Unmet Needs in Diagnostics and Therapeutics of Chronic Lymphocytic Leukemia in Korea [0.03%]
理解韩国慢性淋巴细胞白血病在诊断和治疗方面的未满足需求
Eun Sang Yu,Soyean Kwon,Seonggyu Byeon et al.
Eun Sang Yu et al.
Purpose: Since the FDA approval of ibrutinib in 2012, the treatment landscape for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) has undergone a paradigm shift. Nevertheless, the disease remains i...
A Phase I/II Trial to Evaluate the Safety and Efficacy of Continuous Positive Airway Pressure in Volumetric Modulated Arc Therapy for Breast Cancer [0.03%]
连续阳性气道压力在乳腺癌体调弧形治疗中的安全性和有效性的I/II期试验
Jung Bin Park,Tosol Yu,Jaeman Son et al.
Jung Bin Park et al.
Purpose: This phase I/II study aimed to evaluate the tolerability and the organ-sparing effects of continuous positive airway pressure (CPAP) in breast cancer radiotherapy (RT). ...
Circulating Tumor Cell-based Molecular Responses Stratify EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Cancer [0.03%]
基于循环肿瘤细胞的分子反应可对EGFR突变型肺癌患者TKI疗效进行分层
Seoyoung Lee,Chaeyeon Kim,Chang Gon Kim et al.
Seoyoung Lee et al.
Purpose: Circulating tumor cell (CTC) is a promising minimally invasive biomarker for EGFR-mutant non-small cell lung cancer (NSCLC). However, the rarity of CTCs and limitations in their isolation and molecular characteri...
Biomarker Testing Practices for Non-small Cell Lung Cancer: Survey Insights from South Korean Pathology Laboratories [0.03%]
韩国病理实验室非小细胞肺癌生物标志物检测实践调查见解
Sehui Kim,Dajeong Kim,Lucia Kim et al.
Sehui Kim et al.
Purpose: Molecular biomarker testing is essential for lung cancer management and precision medicine. This study evaluated biomarker testing practices for non-small cell lung cancer across pathology laboratories in South K...
Radiomics-Based Prediction of Lymphedema after Radiotherapy in Breast Cancer: Integrating Clinical and Dosimetric Features [0.03%]
基于影像组学的乳腺癌放疗后淋巴水肿预测：临床和剂量学特征的整合分析
Jae Sik Kim,Seung Hyuck Jeon,Bum-Sup Jang et al.
Jae Sik Kim et al.
Purpose: Arm lymphedema is a common, debilitating complication in patients with breast cancer undergoing postoperative radiotherapy (PORT). Although clinical and dosimetric factors have been used for risk prediction, radi...
Pre-Treatment Ki67 Index for Everolimus Efficacy in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter Cohort Study [0.03%]
一项关于来那替尼疗效的预处理Ki67指数：绝经后激素受体阳性且HER2阴性晚期乳腺癌患者的多中心队列研究
Yujing Tan,Hanfang Jiang,Fei Ma et al.
Yujing Tan et al.
Purpose: The study aims to explore the predictive value of the Ki67 index for everolimus efficacy in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breas...
Salidroside-Loaded, TMTP1-Modified CSC-Exosomes Reprogram the PI3K/AKT/mTOR Axis to Overcome PD-1 Resistance in Breast Cancer [0.03%]
TMTP1修饰的飞鼠胶质母细胞瘤细胞来源的外泌体递送山柳苷胺重编程PI3K/Akt/mTOR轴以克服乳腺癌PD-1耐药性
Faxiang Yin,Xin Jin,Ligong Zhang et al.
Faxiang Yin et al.
Purpose: To elucidate how Salidroside-loaded, oligopeptide-modified tumor exosomes (Salidroside@T-exo) rewire the PI3K/AKT/mTOR axis to remodel the immune microenvironment (IME) and reverse acquired PD-1 resistance in bre...
Trends in Incidence and Survival of Childhood and Adolescent Cancer in Korea, 2001-2020: Comparison with U.S. SEER Data [0.03%]
2001至2020年韩国儿童及青少年癌症的发病率和生存率变化趋势及其与美国SEER数据的对比
Jin Kyung Suh,Eun Hye Park,Meerim Park et al.
Jin Kyung Suh et al.
Purpose: Childhood cancers are rare but clinically significant. Monitoring incidence and survival trends is essential for evaluating progress in cancer control and identifying areas for improvement. ...
Smoking, Alcohol, and Abdominal Obesity Increase Gastric Cancer Risk after Helicobacter pylori Eradication [0.03%]
根除幽门螺杆菌后，吸烟、饮酒和腹型肥胖增加胃癌风险
Joo Hyun Lim,Cheol Min Shin,Kyungdo Han et al.
Joo Hyun Lim et al.
Purpose: Helicobacter pylori is the single most important risk factor for gastric cancer (GC). However, H. pylori eradication (HPE) does not eliminate risk of GC. To clarify the association of lifestyle factors with GC ri...